Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours ยท Estimated delivery Aug 11 - Aug 16
A wave of 2nd generation GLP-1 agonists came to market between 2014-2021, improving clinical outcomes and providing more convenient dosing and administration options
The medication helps control body weight by reducing appetite, increasing insulin release, and slowing gastric emptying
The latest results from the 2023 TEXAIS trial indicated that the use of exenatide (5 g, twice daily injections for 5 days) did not significantly reduce neurological damage within 7 days in patients with acute ischemic stroke (trial registration numbers: ACTRN12617000409370 and NCT03287076)
low blood sugar or low sodium
US$ 28.44
US$ 22.72
US$ 28.29
US$ 27.55
US$ 25.62
US$ 26.82
